The European / Australasian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) Study Group. ESPRIT: safety and efficacy of oral anticoagulation a rebuttal. (letter)

A. Algra

The European / Australasian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) Study Group. ESPRIT: safety and efficacy of oral anticoagulation a rebuttal. (letter)

Translated title of the contribution: The European / Australasian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) Study Group. ESPRIT: safety and efficacy of oral anticoagulation a rebuttal. (letter)

A. Algra

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	The European / Australasian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) Study Group. ESPRIT: safety and efficacy of oral anticoagulation a rebuttal. (letter)
Original language	Undefined/Unknown
Pages (from-to)	184e
Journal	Stroke
Volume	34
Publication status	Published - 2003

Cite this

@article{5a8d4c51b484489881765dc3230c5170,

title = "The European / Australasian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) Study Group. ESPRIT: safety and efficacy of oral anticoagulation a rebuttal. (letter)",

author = "A. Algra",

year = "2003",

language = "Undefined/Unknown",

volume = "34",

pages = "184e",

journal = "Stroke",

issn = "0039-2499",

publisher = "Wolters Kluwer Health",

}